18th June 2019
The enthralling daylong event saw speakers such as Celina McGregor of AstraZeneca, Will James of Osborne Clarke, Kai Gait of GSK and Nicolas Pourbaix of Amgen.
The last and insightful panel of the day, “Globalisation In Life Sciences: Is international Arbitration the future?”, was chaired by former Lord Justice of Appeal Sir Robin Jacob of 8 New Square, with speakers discussing benefits of arbitration for life sciences matters as opposed to the traditional court system. It was joined by Matt Lynde of Cornerstone Research, Laurence Lieberman of Taylor Wessing, Kathleen Denoodt and Greg Bell of Charles River Associates.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.